Lifecycle Management as a Roadmap to the Tobacco Endgame

World Journal of Clinical Medicine Research | Vol 5, Issue 1

Table 7. Phase-Specific Transition Criteria, KPIs, andEquity Checks

Phase → Next Phase	Core Transition Criteria	Key Performance Indicators (KPIs)	Equity Check (Disparities-Sensitive)	Illustrative Data Sources
1 Conception → 2 Design	≥48 states with current prevalence baselines; ≥80% of priority stakeholders engaged	# stakeholder sessions; % mission statements with measurable targets	Equity objectives explicitly included (e.g., menthol, targeted marketing)	CDC NHIS; BRFSS; YRBSS/NYTS; STATE System; state tobacco plans
2 Design → 3 Implementation	≥75% of drafted bills include impact analysis; ≥60% of jurisdictions aligned with federal/state frameworks	Policy drafting cycle time; # of model ordinances adopted	Equity impact assessments completed; anti-preemption safeguards documented	Federal Register; NCSL; state legislature portals
3 Implementation → 4 Evaluation	≥85% of planned campaigns launched; ≥70% retailer inspection coverage; Quitline capacity ≥95%	Campaign reach (% of population); inspections per 1,000 retailers; NRT adequacy index	Service reach parity within 10% across racial/SES groups	FDA compliance database; NAQC reports; state dashboards
4 Evaluation → 5 Consolidation	<8% adult prevalence and ≥20% year-over-year decline in youth vaping	Data release lag <6 months; policy update latency <120 days	Reduction in menthol use disparities ≥25%	MMWR/NYTS; OIG/FDA enforcement logs
5 Consolidation → 6 Sustainment	Endgame package enacted in ≥50% of states; cross-border enforcement coverage ≥80%	% retailers under supply controls; % targeted cessation coverage	No widening of disparities during final push	STATE System; CBP/DOJ taskforce reports
6 Sustainment (steady-state)	Illicit trade cases resolved ≥70%; relapse rate stable/declining over 3 years	Monitoring frequency; community education renewal rate	Prevention grants distributed proportional to burden	CBP/DOJ; state prevention grants